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Ischemia
The	glycocalyx	is	an	underappreciated	component	of	the	endothelial	vascular	layer	that	resides	within	the	lumen	of	blood	vessels.	Due	to	its sensitive	nature,	every	effort	to	protect	its	structure	should	be	utilized.	By	avoiding	ischemia,	hypervolemia,	inflammation,	and	hyperglycemia,	the	risk	of	capillary	leak,	edema,	and	other	complications	can	be	avoided.	Analyzing	the	microcirculation	is	a	promising	new	way	to	detect	early	dysfunction	and	improve	the	outcomes	for	those	who	are	critically	ill.	
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Introduction Pathophysiologic Process ImplicationsDespite	the	lack	of	treatment	options	to	reduce	the	severity	of	damaged	endothelial	glycocalyx,	understanding	its	purpose	and	the	negative	consequences	it	can	have	will	allow	clinicians	to avoid	exposing	their	patients	to	the	main	culprits	of	degradation.Future	research	should	be	focused	on	point-of-care	lab	testing	and	effective	microcirculation-protective	therapies.	
Conclusion
How It Helps:The	endothelial	glycocalyx	is	a	slimy,	gel-like	substance	in	the	shape	of	thin,	hair-like	projections	on	the	inside	of	the	lumen	wall	in	blood	vessels	(see	figure	1).	It is primarily	made	up ofglycoproteins and	proteoglycans.	Glycoproteins are	proteins	that	have	carbohydrate	groups	attached	to	a	polypeptide	chain	while	proteoglycans	are	proteins	bonded	to	glycosaminoglycan	groups. Without plasmaconstituents binding	to	theglycocalyx	such	as	albumin,	the	glycocalyx	has	no	active	physiologic	role.		Once	the	structure	binds	plasma	constituents,	like	albumin	to	its	surface,	they	together	form	the	active	endothelial	surface	layer.	The	surface	has	a	net	negative	charge	and	repels	other	negatively	charged	molecules	as	well	as	red	and	white	blood	cells	along	with	platelets	(Alphonsus	&	Rodseth,	2014).
By administering too muchIV fluid, preload of the heartincreases. As	the	right	atria	and	left	ventricle	begin	to	stretch,	natriuretic	peptides	are	released	and	activate	metalloproteinases	that	digest	the	glycocalyx.	This	is	especially	true	if	the	IV	fluid	is	albumin	and	the	patient	is	normovolemic prior	to	the	infusion	since	albumin	is	made	up	of	larger	molecules	and	stays	in	the	intravascular	space	longer	(Chappell	&	Jacob,	2014;	O’Connor	&	Prowle,	2015)	
While	most	clinicians	have	a	basic	understanding	of	the	human	body’s	“pumps	and	pipes,”	many	do	not	know	that	blood	vessels	contain	a	special	protective	layer	called	the	endothelial	glycocalyx.	Its	unique	composition	and	function	make	it	important	to	more	than	several	pathophysiologic	processes	in	the	body.	When	the endothelialglycocalyx is damaged,	the	luminal	side	of	the	endothelium	is	no	longer	protected	and	complications	can	occur.	There	are	four	main	identifiable	reasons	that	contribute	to	the	degradation	of	the	glycocalyx	and	surprisingly,	all	are	very	common	among	those	who	are	critically	ill.	This	structure	is	worth	discussing	because	it	ultimately	dictates	the	severity	of	hemodynamic	compromise	that	can	occur	once	the	glycocalyx	is	degraded.	By	avoiding	damage,	the	hope	is	that	both	morbidity	and	mortality	can	be	reduced.	
• Regulates	vascular	permeability	by	acting	as	a	double	barrier	to	large	and	small	molecules
• Regulates vascular tone
• Protects endothelial cellsfrom shear stress
• Prevents	adhesion	of	white	blood	cells	and	platelets	to	vessel	wall
• Docks	coagulation	enzymes	creating	antithrombotic	effect invasculature
• Allows	red	blood	cells	to	flow	smoothly	through	vessel	(Biddle,	2014)
Otterbein University, Westerville, Ohio
Figure	1.	Microscopy	of	vessel	lumen	with	enlargement	of	glycocalyx.	Source:	
(Roberson	&	Watton,	2013)
Hypervolemia
Elevated	blood	glucose,	especially	in	type-1	diabetic	patients,	degrades	the	glycocalyx.	Research	has	shown	that	type-1	diabetics	have	half	the	thickness	of	a	normal	glycocalyx	when	compared	to	non-diabetic	counterparts	(Alphonsus	&	Rodseth,	2014).	Even	in	healthy,	non-diabetics,	6	hours	of	hyperglycemia	degrades	the	systemic	glycocalyx	by	50%	(Biddle,	2014).
HyperglycemiaInflammatory	mediators,	such	as	cytokines,	in	trauma	and	septic patients degrade	the	glycocalyx.	The	cleavage	of	the	glycocalyx	renders	the	endothelium	bare;	this	contributes	to	capillary	leakage	(Chen,	2016a).	Also,	shearing	stress	to	the	endothelium	causes	release	of	nitric	oxide	which	in	turn	causes	vasodilation	of	blood	vessels.	This	is	one	reason	why	septic	patients	are	profoundly	hypotensive	in	addition	to	the	hypovolemia	caused	by	fluid	leaking	out	into	the	interstitial	space.	Serum	levels	of	glycocalyx	degradation	in	septic	patients	are	correlated	with	worse	outcomes	(Chen,	2016b).
Inflammation
Signs and symptoms	of	a	damaged	glycocalyx	include:
• Capillary leak
• Edema
• Increased	inflammation
• Platelet aggregation
• Hypercoagulability
• Loss of vascular tone(Biddle, 2014)
Damaged Endothelial Glycocalyx Worsens 
Patient OutcomesLab	data	that	shows	an	elevation	in serum glycocalyx	shedding	positively	correlates	with	a	worsened	clinical	outcome	in	critical	illness	(Colbert	&	Schmidt,	2016).	When	the	glycocalyx	is	damaged,	parts	of	the	structure	are	broken	down	and	the	flow	of	blood	releases	these	parts	into	circulation(seefigure 2).
Using	glycocalyx	degradation	as	a	marker	for	severity	of	endothelial	damage	and/or	critical	illness	may	be	a	potential	laboratory	value	of	merit. It mayalso be a new screening	tool forsepsis	(Martin,	Koczera,	Zechendorf,	&	Schuerholz,	2016).	Currently,	there	is	not	enough	research	to	demonstrate	its	routine	use.	Point-of-care	testing	may	be	worth	further	research.	
Microcirculation-protective	therapies	like	steroids,	colloids,	vasopressors,	and	anticoagulants	were	initially	thought	to	protect	the	glycocalyx,	however,	outcomes	in	clinical	trials	have	shown	no	therapeutic	benefit	(Colbert	&	Schmidt,	2016).	Currently,	there	are	no	recommended	treatments	other	than	treating	the	underlying	cause.	
Lab Testing & Treatment
Without oxygen, theglycocalyx	begins	to	degrade	and	shed	its	full,	thick	coat.	The	vessels	that	supply	blood	to	the	heart	as	well	as	the	vessels	that	supply	blood	to	the	central	nervous	system	are	particularly	more	sensitive	to	ischemia	(see	figure	2).	Once	shedding	starts,	leukocyte	and	platelet	adhesion	to	the	epithelial	surface	exacerbates	the	injury	(Biddle,	2014).	Higher	concentrations	of	serum	glycocalyx	components	have	been	noted	particularly	in	peripheral	arterial	surgery	and	coronary	artery	bypass	surgery	(Alphonsus	&	Rodseth,	2014).
Composition:
Figure	2.	Microscopy	before	and	after	ischemia	has	damaged	the	glycocalyx	.	
Source:	(Biddle,	2014)
Main Culprits
